share_log

Organigram Q4 Revenue Grows 83% YoY, Provides Outlook

Organigram Q4 Revenue Grows 83% YoY, Provides Outlook

OrganiGram第四季度收入同比增长83%,提供展望
Benzinga Real-time News ·  2022/11/29 07:56
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) released its results for the fourth quarter and year ended August 31, 2022, revealing net revenue in FY 2022 increased 84% to $145.8 million from $79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.
OrganiGram Holdings Inc.纳斯达克(TSX:OGI)(多伦多证券交易所股票代码:OGI)发布了截至2022年8月31日的第四季度和年度业绩,披露净收入在2022财年增长84%,达到1.458亿美元这主要是由于娱乐和国际收入增加,但部分被医疗销售额的下降所抵消。
Q4 and Fiscal 2022 Financial Highlights
第四季度和2022财年财务亮点
Net revenue increased 83% to $45.5 million in Q4 2022, from $24.9 million in Q4 fiscal 2021. Gross margin before fair value changes to biological assets, inventories sold, and other charges:
2022年第四季度净收入增长83%,从2021财年第四季度的2490万美元增至4550万美元。 生物资产、出售的存货和其他费用的公允价值变动前的毛利率:
Q4 fiscal 2022 margin improved to $8.8 million from negative $1.0 million in Q4 fiscal 2021. In fiscal 2022, margin improved to $26.8 million from negative $24.4 million in fiscal 2021. Adjusted...
2022财年第四季度利润率从2021财年第四...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发